Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| IN8BIO, INC. | 22,000 | reported | 09 May 2026 | tx 25+1,627,581−409,835 |
| Opus Genetics, Inc. | 3,537 | reported | 06 Jun 2019 | tx 28+798,279 |
| AUXILIUM PHARMACEUTICALS INC | 0 | reported | 29 Jan 2015 | tx 17+70,000−70,000 |
| EPOCRATES INC | 0 | reported | 12 Mar 2013 | tx 19+238,825−181,959 |
| NOVEN PHARMACEUTICALS INC | 0 | reported | 27 Aug 2009 | tx 19+857,712−857,712 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 May 2026 | GRANT_AWARD | IN8BIO, INC. | 22,000 | 0.00 USD | deriv |
| 22 Dec 2025 | GRANT_AWARD | IN8BIO, INC. | 72,464 | 1.38 USD | |
| 08 May 2025 | GRANT_AWARD | IN8BIO, INC. | 63,150 | 0.00 USD | deriv |
| 30 Apr 2025 | EXERCISE | IN8BIO, INC. | 81,967 | 0.18 USD | |
| 30 Apr 2025 | EXERCISE | IN8BIO, INC. | 81,967 | 0.18 USD | |
| 30 Apr 2025 | EXERCISE | IN8BIO, INC. | 81,967 | 0.00 USD | deriv |
| 27 Apr 2025 | GRANT_AWARD | IN8BIO, INC. | 81,967 | — | deriv |
| 30 Apr 2025 | EXERCISE | IN8BIO, INC. | 81,967 | 0.00 USD | deriv |
| 27 Apr 2025 | OTHER | IN8BIO, INC. | 81,967 | — | deriv |
| 27 Apr 2025 | GRANT_AWARD | IN8BIO, INC. | 81,967 | — | deriv |
| 27 Apr 2025 | OTHER | IN8BIO, INC. | 81,967 | — | deriv |
| 19 Dec 2024 | GRANT_AWARD | IN8BIO, INC. | 49,490 | 0.00 USD | deriv |
| 04 Oct 2024 | GRANT_AWARD | IN8BIO, INC. | 253,164 | — | |
| 04 Oct 2024 | GRANT_AWARD | IN8BIO, INC. | 253,164 | — | deriv |
| 04 Oct 2024 | OTHER | IN8BIO, INC. | 81,967 | — | deriv |
| 04 Oct 2024 | GRANT_AWARD | IN8BIO, INC. | 81,967 | — | deriv |
| 12 Jun 2024 | GRANT_AWARD | IN8BIO, INC. | 33,650 | 0.00 USD | deriv |
| 13 Dec 2023 | GRANT_AWARD | IN8BIO, INC. | 81,967 | — | |
| 13 Dec 2023 | GRANT_AWARD | IN8BIO, INC. | 81,967 | — | deriv |
| 13 Dec 2023 | GRANT_AWARD | IN8BIO, INC. | 81,967 | — | deriv |
| 15 Jun 2023 | GRANT_AWARD | IN8BIO, INC. | 85,000 | 0.00 USD | deriv |
| 16 Aug 2022 | PURCHASE | IN8BIO, INC. | 105,263 | 1.90 USD | first after silence |
| 01 Jun 2022 | GRANT_AWARD | IN8BIO, INC. | 10,500 | 0.00 USD | deriv |
| 29 Jul 2021 | GRANT_AWARD | IN8BIO, INC. | 10,500 | 0.00 USD | deriv |
| 06 Jun 2019 | GRANT_AWARD | Opus Genetics, Inc. | 3,537 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 16 Aug 2022.